Villaren, Rafael E.
HRN: 26-44-02 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/29/2025
METRONIDAZOLE 125MG/5ML, 60ML (BOT)
04/29/2025
05/08/2025
IV
4
Q8hrs
Amoebiasis
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes